News 27.08.2018 ProteoMediX AG, a diagnostic company developing blood-based tests for the accurate diagnosis and prognosis of prostate cancer, has announced the successful closing of an equity financing round. The company raised CHF 5.2 million (€ 4.6 million) from existing investors. Altos Venture (Allschwil, Switzerland), a Swiss venture capital firm chaired by Dr....
Internal events
Event date: 27.09.2018
Continuous bioprocessing is improving the process stability, flexibility and profitability of pharmaceutical manufacturing. Pall develops innovative solutions tailored to manufacturers needs implementing continuous manufacturing.
Place: Auditorium, Wagistrasse 25
Program:
08:45 - 09:00 Coffee & Croissants
09:00 - 09:45 Presentation: Continuous Bioprocessing in pharmaceutical manufacturing
10:00 - 12:00 Session 1: Clarification & sterile filtration /...
News 19.07.2018 DUBLIN, IRELAND – July 19, 2018– Allergan plc, (NYSE: AGN), a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, today announced the release of two positive clinical trials, SEQUOIA and CEDAR for abicipar, demonstrating that...
News 02.07.2018 Schlieren (Zurich), Switzerland, July 2, 2018 – Kuros Biosciences (SIX: KURN) announced today it recorded the first commercial use last week of MagnetOs in the U.S., and the company expects to ramp up its commercial activities in Europe and the U.S. in the second half of 2018. Joshua M. Ammerman, M.D....
External events
Event date: 15.09.2018
To enhance the interactions between academia, industry, and society by bringing together all relevant stakeholder groups from universities, industry and medicine to discuss topics pertaining to new technologies, drug discovery, personalized medicine, and open science and innovation.
More information